New England Journal of Medicine 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function
N Engl J Med 2022; 387:1173-1184
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation
N Engl J Med. 2022 Jul 14;387(2):120-131.
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
N Engl J Med. 2022 Jun 9;386(23):2178-2187
Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma
N Engl J Med. 2022 Jun 2;386(22):2071-2083
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
NEJM 2022; 386:1973-1985
Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma
NEJM 2022; 386:1505-1518
Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia
N Engl J Med 2022 Mar 24; 386:1121-1131
Review Article: Cryptogenic Organizing Pneumonia
N Engl J Med 2022 Mar 17; 386:1058-1069
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children
N Engl J Med 2022 Mar 10; 386:911-922
Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray
N Engl J Med 2022 Mar 3; 386:861-868
https://www.nejm.org/doi/full/10.1056/NEJMoa2116130
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
N Engl J Med 2022 Jan 20; 386:241-251
Review Article: Biologic Therapies for Severe Asthma
N Engl J Med 2022 Jan 13; 386:157-171
